The burden of acute myeloid leukemia: an integrated review of clinical, economic, and patient-centered evidence.

Zeidan AM, Zhao R, Christensen D, Amin J, LeBlanc TW

Open source

DOI
10.1080/14737140.2026.2705531
Published
2026 Aug 6
Container
Expert review of anticancer therapy
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/14737140.2026.2705531,
  title = {The burden of acute myeloid leukemia: an integrated review of clinical, economic, and patient-centered evidence.},
  author = {Zeidan AM and Zhao R and Christensen D and Amin J and LeBlanc TW},
  year = {2026},
  journal = {Expert review of anticancer therapy},
  doi = {10.1080/14737140.2026.2705531},
  url = {https://doi.org/10.1080/14737140.2026.2705531}
}

RIS

TY  - JOUR
TI  - The burden of acute myeloid leukemia: an integrated review of clinical, economic, and patient-centered evidence.
AU  - Zeidan AM
AU  - Zhao R
AU  - Christensen D
AU  - Amin J
AU  - LeBlanc TW
PY  - 2026
JO  - Expert review of anticancer therapy
DO  - 10.1080/14737140.2026.2705531
UR  - https://doi.org/10.1080/14737140.2026.2705531
ER  - 

APA

AM, Z., R, Z., D, C., J, A., & TW, L. (2026). The burden of acute myeloid leukemia: an integrated review of clinical, economic, and patient-centered evidence.. Expert review of anticancer therapy. https://doi.org/10.1080/14737140.2026.2705531

Source records